LEXARIA BIOSCIENCE CORP. (LEXX) Net income 2016–2025
LEXARIA BIOSCIENCE CORP. (LEXX) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$11.9MFY2025 · since FY2016: -$1.3M → -$11.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$11.9M | -105.4% |
| FY2024 | -$5.8M | +13.0% |
| FY2023 | -$6.7M | +8.3% |
| FY2022 | -$7.3M | -80.5% |
| FY2021 | -$4.0M | +1.4% |
| FY2020 | -$4.1M | -199.6% |
| FY2019 | $4.1M | -37.9% |
| FY2018 | $6.6M | +442.1% |
| FY2017 | -$1.9M | -51.1% |
| FY2016 | -$1.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More LEXX financial trends
LEXX RevenueLEXX Net marginLEXX Gross profitLEXX Gross marginLEXX Operating incomeLEXX Operating marginLEXX Operating cash flowLEXX Free cash flowLEXX Capital expendituresLEXX Return on equityLEXX Stock buybacksLEXX Dividends paidLEXX Total assetsLEXX Total liabilitiesLEXX Shareholders’ equityLEXX overview →